Schedule 13G ownership disclosure
Forte Biosciences Inc
Common Stock, par value $0.001 per share · CUSIP: 34962G208
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Perceptive Advisors LLC
Shares: 163,935 · Class: 2.5%
- Joseph Edelman
Shares: 163,935 · Class: 2.5%
- Perceptive Life Sciences Master Fund, Ltd.
Shares: 163,935 · Class: 2.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-021236
- Form type
- SCHEDULE 13G/A
- Filer
- Forte Biosciences, Inc.
- CIK
- CIK 1419041
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership